LORAZEPAM AND HYDROMORPHONE FOR CONSCIOUS SEDATION AND ANALGESIA

劳拉西泮和氢吗啡酮用于清醒镇静和镇痛

• 批准号: 6278549
• 负责人: T E WITZIG
• 金额: $ 2.03万
• 依托单位: MAYO CLINIC ROCHESTER
• 依托单位国家: 美国
• 财政年份: 1997
• 资助国家: 美国
• 起止时间: 1997-12-01 至 1998-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6278549
• 关键词: analgesia; analgesics; anxiety; biopsy; bone marrow; clinical research; human subject; human therapy evaluation; lorazepam; neoplasm /cancer classification /staging; oral administration; pain; preoperative state

Patients undergoing bone marrow biopsy will be premedicated with lorzepam and hydromorphone to assess whether this regimen will reduce anxiety and pain compared to local anesthesia alone. This protocol was a double-blind placebo controlled trial of oral analgesia for patients undergoing bilateral bone marrow biopsies for staging of lymphoma. Our hypothesis was that patients would experience less pain and distress when they had oral analgesics.

接受骨髓活检的患者将预先服用 评估这种疗法是否会减少 与单纯的局部麻醉相比，焦虑和疼痛。 这是一项口服双盲安慰剂对照试验。 双侧骨髓活检患者的止痛效果观察 淋巴瘤的分期。我们的假设是患者会经历 当他们服用口服止痛剂时，疼痛和痛苦较少。